Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Kim DW, Schram AM, Hollebecque A, Nishino K, Macarulla T, Rha SY, Duruisseaux M, Liu SV, Al Hallak MN, Umemoto K, Wesseler C, Cleary JM, Springfeld C, Neuzillet C, Joe A, Jauhari S, Ford J, Goto K. Kim DW, et al. Among authors: ford j. Future Oncol. 2024 Feb 13. doi: 10.2217/fon-2023-0824. Online ahead of print. Future Oncol. 2024. PMID: 38348690 Review.
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
Schram AM, Odintsov I, Espinosa-Cotton M, Khodos I, Sisso WJ, Mattar MS, Lui AJW, Vojnic M, Shameem SH, Chauhan T, Torrisi J, Ford J, O'Connor MN, Geuijen CAW, Schackmann RCJ, Lammerts van Bueren JJ, Wasserman E, de Stanchina E, O'Reilly EM, Ladanyi M, Drilon A, Somwar R. Schram AM, et al. Among authors: ford j. Cancer Discov. 2022 May 2;12(5):1233-1247. doi: 10.1158/2159-8290.CD-21-1119. Cancer Discov. 2022. PMID: 35135829 Free PMC article.
Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
Liu S, Shen T, Huynh L, Klisovic MI, Rush LJ, Ford JL, Yu J, Becknell B, Li Y, Liu C, Vukosavljevic T, Whitman SP, Chang KS, Byrd JC, Perrotti D, Plass C, Marcucci G. Liu S, et al. Among authors: ford jl. Cancer Res. 2005 Feb 15;65(4):1277-84. doi: 10.1158/0008-5472.CAN-04-4532. Cancer Res. 2005. PMID: 15735013
The Rise of the Term "Latinx" in Medical Research.
Ford JS, Rodriguez RM, Molina MF. Ford JS, et al. J Gen Intern Med. 2024 Jun 3. doi: 10.1007/s11606-024-08840-5. Online ahead of print. J Gen Intern Med. 2024. PMID: 38831245 No abstract available.
Residual bioefficacy of attractive targeted sugar bait stations targeting malaria vectors during seasonal deployment in Western Province of Zambia.
Mwaanga G, Ford J, Yukich J, Chanda B, Ashton RA, Chanda J, Munsanje B, Muntanga E, Mulota M, Simuyandi C, Mulala B, Simubali L, Saili K, Simulundu E, Miller J, Hamainza B, Orange E, Wagman J, Mburu MM, Harris AF, Entwistle J, Littrell M. Mwaanga G, et al. Among authors: ford j. Malar J. 2024 May 29;23(1):169. doi: 10.1186/s12936-024-04990-3. Malar J. 2024. PMID: 38811947 Free PMC article.
Prediction of Readmission Following Sepsis Using Social Determinants of Health.
Amrollahi F, Kennis BD, Shashikumar SP, Malhotra A, Taylor SP, Ford J, Rodriguez A, Weston J, Maheshwary R, Nemati S, Wardi G, Meier A. Amrollahi F, et al. Among authors: ford j. Crit Care Explor. 2024 May 24;6(6):e1099. doi: 10.1097/CCE.0000000000001099. eCollection 2024 Jun 1. Crit Care Explor. 2024. PMID: 38787299 Free PMC article.
Promotion of Influenza Vaccination in the Emergency Department.
Rodriguez RM, Eucker SA, Rafique Z, Nichol G, Molina MF, Kean E, O'Laughlin KN, Bezek SK, Goicochea K, Ford JS, Morse D, White J, Arreguin MI, Shughart L, Chavez CL, Glidden DV, Rising KL. Rodriguez RM, et al. Among authors: ford js. NEJM Evid. 2024 Apr;3(4):EVIDoa2300197. doi: 10.1056/EVIDoa2300197. Epub 2024 Mar 26. NEJM Evid. 2024. PMID: 38776635 Clinical Trial.
3,706 results